Clinical Trial Update: Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating posaconazole prophylaxis in patients receiving hematopoietic stem cell allografts at high risk of invasive fungal infections…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Nantes University Hospital | Conditions: Hematologic Malignancy | Phase 2 | Status: RECRUITING